Toggle Health Problems and D

Institute of Medicine (which recommended low vitamin D) has many conflicts of interest – July 2014

Premier Government Body of Science and Medicine Turning Into Yet Another Agency for Corporate Science Mercola July 2014

Snips – Pain panel

  • A Journal Sentinel/MedPage Today investigation found that nine of the 19 experts on the IOM panel that produced that report had connections to companies that manufacture narcotic painkillers at the time or in the three years prior to their work on the report.”
  • Indeed, six of the IOM panel members have been officers or board members of advocacy groups that were named in a 2012 U.S. Senate Committee on Finance investigation into the links. Details at http://www.medpagetoday.com/PainManagement/PainManagement/46482
  • For starters, the chairman of the IOM’s pain panel, Phillip Pizzo, MD, was formerly the dean of Stanford Medical School. Less than a year before the pain panel convened, Stanford received a $3 million medical education grant from Pfizer

Snips – IoM others

  • IOM’s new President, Victor Dzau,9, 10 is on the board of directors of
      Alnylam Pharmaceuticals, and
  • Dr. Paul Offit, who became an IOM member in 2011 -received a $350,000 grant from Merck to develop a rotavirus vaccine,
  • Dr. Offit gets $90,000 a year from a Merck-endowed chair

See also VitaminDWiki

See also web

  • Big Pharma Drug watch
    contributes heavily to the annual budget of the U.S. Food and Drug Administration (FDA),
    1,100-plus paid lobbyists
    From 1998 to 2013, Big Pharma spent nearly $2.7 billion on lobbying expenses
       42 % more than the second highest paying industry: insurance.
Top 10 Big Pharma 2012 sales
Johnson & Johnson $67.2 Billion
Pfizer$58.9 Billion
Novartis $56.7 Billion
Roche $47.8 Billion
Merck $47.3 Billion
Sanofi $46.4 Billion
GlaxoSmithKline $39.9 Billion
Abbot Laboratories/AbbVie $39.9 Billion
AstraZeneca $28 Billion
Bayer HealthCare $24.3 Billion
See any problem with this page? Report it (FINALLY WORKS)